AstraZeneca says its COVID-19 vaccine was 74 percent effective in US testing | The Hill: Healthcare Policy

British drugmaker AstraZeneca's COVID-19 vaccine Vaxzevria has been found to have a 74 percent efficacy in preventing symptomatic disease, according to a report published Wednesday in the New England Journal of Medicine. The report,&...